Development and Internal Validation of Novel Nomograms Based on Benign Prostatic Obstruction-Related Parameters to Predict the Risk of Prostate Cancer at First Prostate Biopsy-Reference-Cited by-同舟云学术

Development and Internal Validation of Novel Nomograms Based on Benign Prostatic Obstruction-Related Parameters to Predict the Risk of Prostate Cancer at First Prostate Biopsy

Published:2018-10-16 Issue: Volume:8 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Cormio Luigi,Cindolo Luca,Troiano Francesco,Marchioni Michele,Di Fino Giuseppe,Mancini Vito,Falagario Ugo,Selvaggio Oscar,Sanguedolce Francesca,Fortunato Francesca,Schips Luigi,Carrieri Giuseppe

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference26 articles.

1. Risk profiles of prostate cancers identified from UK primary care using national referral guidelines;Serag;Br J Cancer,2012

2. Positive predictive value of prostate biopsy indicated by prostate-specific-antigen-based prostate cancer screening: trends over time in a European randomized trial;Bokhorst;BJU Int.,2012

3. Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis;Louie;Ann Oncol.,2015

4. Development and internal validation of a prostate health index based nomogram for predicting prostate cancer at extended biopsy;Lughezzani;J Urol.,2012

5. External validation of urinary PCA3-based nomograms to individually predict prostate biopsy outcome;Auprich;Eur Urol.,2010

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies;International Journal of Molecular Sciences;2023-01-26

2. A Novel Nomogram Combined the Aggregate Index of Systemic Inflammation and PIRADS Score to Predict the Risk of Clinically Significant Prostate Cancer;BioMed Research International;2023-01-12

3. Prebiopsy bpMRI and hematological parameter-based risk scoring model for predicting outcomes in biopsy-naive men with PSA 4–20 ng/mL;Scientific Reports;2022-12-19

4. Oncological outcomes of whole-gland cryoablation in patients with prostate cancer and high risk of lymph node invasion;Urology Annals;2022-11-08

5. A Matched-Pair Analysis after Robotic and Retropubic Radical Prostatectomy: A New Definition of Continence and the Impact of Different Surgical Techniques;Cancers;2022-09-07